Five Prime Therapeutics and Personal Genome Diagnostics collaborate to develop new diagnostic assay for gastric and gastrointestinal cancers
From rhinos to chemical warfare agents, we bring you the latest in forensics and toxicology
A blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests
Read this exclusive interview with Louise Kenny, one of the founding directors of the INFANT Centre, to discover how they are using mass spectrometry to research preeclampsia and pre-term birth
An optimized, automated workflow enables continued growth of the clinical mass spectrometry service at this leading London Trust
Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute
The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today’s difficult assays, and the versatility to address tomorrow’s precision medicine and wellness testing
Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease
Read exclusive interviews from experts in healthcare settings around the world, to discover how mass spectrometry is improving clinical diagnostics
Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research
New test to identify IBS sufferers who respond to diet restrictions
New blood test identifies 12 metabolic sub-types of autism spectrum disorder
Next-generation mass spectrometry-based solution analyzes dried blood spots from newborn babies to test for wide range of metabolic disorders
FreeStyle Libre system can eliminate the need for routine fingersticks or any user calibration
Clinical laboratories gain greater confidence in opioid testing with proven high-specificity and high-sensitivity
U.S. labs now able to use the automated Anti-Müllerian Hormone (AMH) assay with the access 2 or DxI Immunoassay systems
Flagship exhibition will be held at the Dubai International Convention & Exhibition Centre, Dubai, UAE in February 2018
